GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
US6264629B1
(en)
|
1998-11-18 |
2001-07-24 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6132395A
(en)
*
|
1998-12-08 |
2000-10-17 |
Bioject, Inc. |
Needleless syringe with prefilled cartridge
|
US6383168B1
(en)
|
1998-12-08 |
2002-05-07 |
Bioject Medical Technologies Inc. |
Needleless syringe with prefilled cartridge
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
US7029457B2
(en)
*
|
1999-11-23 |
2006-04-18 |
Felton International, Inc. |
Jet injector with hand piece
|
US6558348B2
(en)
|
2000-04-07 |
2003-05-06 |
Equidyne Systems, Inc. |
Low cost disposable needleless injector system for variable and fixed dose applications
|
WO2001087385A1
(en)
|
2000-05-16 |
2001-11-22 |
Weston Medical Limited |
Liquid transfer device for drug reconstitution or liquid drug transfer
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
EP2269639B1
(en)
|
2001-02-23 |
2018-11-28 |
GlaxoSmithKline Biologicals s.a. |
Influenza vaccine formulations for intradermal delivery
|
JP2002263106A
(en)
*
|
2001-03-12 |
2002-09-17 |
Olympus Optical Co Ltd |
Optical probe device
|
US6500239B2
(en)
|
2001-03-14 |
2002-12-31 |
Penjet Corporation |
System and method for removing dissolved gas from a solution
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US6613010B2
(en)
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
EP1427463A2
(en)
|
2001-04-27 |
2004-06-16 |
PenJet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
GB0125506D0
(en)
*
|
2001-10-24 |
2001-12-12 |
Weston Medical Ltd |
Needle free injection method and apparatus
|
GB0206560D0
(en)
*
|
2002-03-20 |
2002-05-01 |
Glaxo Group Ltd |
Novel device
|
MY139059A
(en)
|
2002-06-24 |
2009-08-28 |
Alza Corp |
Reusable, spring driven autoinjector
|
AU2002336381A1
(en)
|
2002-08-26 |
2004-03-11 |
Penjet Corporation |
Apparatus for needle-less injection with a degassed fluid
|
EP1664322B1
(en)
|
2003-05-22 |
2013-07-10 |
Fraunhofer USA, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
WO2005034949A1
(en)
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
DE10342058B4
(en)
*
|
2003-09-11 |
2007-10-25 |
Tecpharma Licensing Ag |
Administration device for an injectable product with a trigger safety device
|
PT2332968T
(en)
|
2003-11-05 |
2016-08-17 |
Harvard College |
Alpha-helical peptides suitable for activating or inhibiting cell death
|
US7776007B2
(en)
|
2003-12-05 |
2010-08-17 |
Zogenix, Inc. |
Device for readying a needle free injector for delivery
|
US7717874B2
(en)
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
US20060005844A1
(en)
*
|
2004-07-08 |
2006-01-12 |
Coulter George G |
Rolling tube apparatus and method for treating a wound
|
ES2540770T3
(en)
|
2004-09-22 |
2015-07-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition for use in staphylococcal vaccination
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
NZ556186A
(en)
|
2004-12-01 |
2010-06-25 |
Acushot Inc |
Needle-free injector
|
TW200722101A
(en)
|
2005-03-23 |
2007-06-16 |
Glaxosmithkline Biolog Sa |
Novel composition
|
BRPI0610644B8
(en)
|
2005-04-04 |
2021-05-25 |
Univ Florida |
compound and pharmaceutical composition comprising such compound and a pharmaceutically acceptable carrier or diluent.
|
AU2006341615A1
(en)
|
2005-08-03 |
2007-10-18 |
Fraunhofer Usa, Inc. |
Compositions and methods for production of immunoglobulins
|
US20070055199A1
(en)
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Drug delivery device for buccal and aural applications and other areas of the body difficult to access
|
TWI457133B
(en)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
Novel composition
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
PT1962899E
(en)
|
2005-12-22 |
2011-10-19 |
Glaxosmithkline Biolog Sa |
Pneumococcal polysaccharide conjugate vaccine
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AU2007215080A1
(en)
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
EA020459B1
(en)
|
2006-03-30 |
2014-11-28 |
Глаксосмитклайн Байолоджикалс С.А. |
Immunogenic composition
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
CN101573141B
(en)
|
2006-05-15 |
2016-05-04 |
麻省理工学院 |
For the polymer of functional particles
|
CA2656298A1
(en)
|
2006-06-02 |
2007-12-13 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
DE602007008562D1
(en)
*
|
2006-06-13 |
2010-09-30 |
Nordson Corp |
LIQUID EDITION SYRINGE
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
DK2043682T3
(en)
|
2006-07-17 |
2014-06-02 |
Glaxosmithkline Biolog Sa |
INFLUENZA VACCINE
|
WO2008021367A2
(en)
|
2006-08-11 |
2008-02-21 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
US7547293B2
(en)
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
JO3598B1
(en)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
Boronic acids and esters as inhibitors of fatty acid amide hydrolase
|
EP2086582B1
(en)
|
2006-10-12 |
2012-11-14 |
GlaxoSmithKline Biologicals s.a. |
Vaccine comprising an oil in water emulsion adjuvant
|
WO2008043774A1
(en)
|
2006-10-12 |
2008-04-17 |
Glaxosmithkline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
JP2010528981A
(en)
|
2006-12-01 |
2010-08-26 |
アンテリオス, インコーポレイテッド |
Amphiphilic entity nanoparticles
|
PT2114873E
(en)
|
2006-12-26 |
2013-05-06 |
Lantheus Medical Imaging Inc |
N-[3-bromo-4-(3- [18f]fluoropropoxy)-benzyl]-guanidine for imaging cardiac innervation
|
JP5649825B2
(en)
|
2007-01-31 |
2015-01-07 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Stabilized p53 peptides and methods of use thereof
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008103997A2
(en)
|
2007-02-23 |
2008-08-28 |
Bioject Inc. |
Needle-free injection devices and drug delivery systems therefor
|
CN104003955A
(en)
|
2007-03-15 |
2014-08-27 |
佛罗里达大学研究基金公司 |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
KR101525754B1
(en)
|
2007-03-28 |
2015-06-09 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Stitched polypeptides
|
EP2144600A4
(en)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
Poly (amino acid) targeting moieties
|
WO2008134643A2
(en)
|
2007-04-28 |
2008-11-06 |
Fraunhofer Usa, Inc. |
Trypanosoma antigens, vaccine compositions, and related methods
|
WO2008138908A1
(en)
*
|
2007-05-14 |
2008-11-20 |
Shl Medical Ab |
Delivery device
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
BRPI0813644B8
(en)
|
2007-06-26 |
2021-05-25 |
Glaxosmithkline Biologicals Sa |
immunogenic composition, vaccine, process to manufacture the same, and use of the immunogenic composition or vaccine
|
CA2692933C
(en)
|
2007-07-11 |
2016-10-18 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
US8604004B2
(en)
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP2620157A3
(en)
|
2007-10-12 |
2013-10-16 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
WO2009089119A2
(en)
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
PL2271360T3
(en)
|
2008-04-16 |
2016-03-31 |
Glaxosmithkline Biologicals Sa |
Vaccine
|
ES2563061T3
(en)
|
2008-04-28 |
2016-03-10 |
Zogenix, Inc. |
New formulations for the treatment of migraine
|
US20110212157A1
(en)
|
2008-06-26 |
2011-09-01 |
Anterios, Inc. |
Dermal delivery
|
EP2318832B1
(en)
|
2008-07-15 |
2013-10-09 |
Academia Sinica |
Glycan arrays on ptfe-like aluminum coated glass slides and related methods
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
WO2010034032A2
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutic, Inc. |
Methods for preparing purified polypeptide compositions
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
EP2376619A4
(en)
|
2008-12-15 |
2012-07-04 |
Greenlight Biosciences Inc |
Methods for control of flux in metabolic pathways
|
DE102008063519A1
(en)
*
|
2008-12-18 |
2010-07-01 |
Lts Lohmann Therapie-Systeme Ag |
Disposable injector with a flexurally elastic metal housing
|
DE102008063517A1
(en)
*
|
2008-12-18 |
2010-07-01 |
Lts Lohmann Therapie-Systeme Ag |
Disposable injector with a flexurally elastic housing II
|
JP2012515172A
(en)
|
2009-01-14 |
2012-07-05 |
エルロン・セラピューティクス・インコーポレイテッド |
Peptidomimetic macrocycle
|
WO2010129023A2
(en)
|
2009-04-28 |
2010-11-11 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
EP2438046A4
(en)
|
2009-06-01 |
2013-04-17 |
Harvard College |
O-glcnac transferase inhibitors and uses thereof
|
JP2012532929A
(en)
|
2009-07-13 |
2012-12-20 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
Bifunctional stapled polypeptides and their use
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
US20130072439A1
(en)
|
2009-09-22 |
2013-03-21 |
Huw M. Nash |
Peptidomimetic macrocycles
|
EP2483307A1
(en)
|
2009-09-29 |
2012-08-08 |
Fraunhofer USA, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
GB2477487A
(en)
*
|
2009-10-12 |
2011-08-10 |
Owen Mumford Ltd |
Injection device
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
GB0921295D0
(en)
*
|
2009-12-04 |
2010-01-20 |
Owen Mumford Ltd |
Injection appaeratus
|
ES2802623T3
(en)
|
2010-01-27 |
2021-01-20 |
Massachusetts Inst Technology |
Polypeptide Agents Technically Designed for Broad Spectrum Targeted Neutralization of Influenza
|
EP2544674B1
(en)
|
2010-03-08 |
2017-10-25 |
Sloan Kettering Institute For Cancer Research |
Cdc7 kinase inhibitors and uses thereof
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
WO2011119549A1
(en)
|
2010-03-22 |
2011-09-29 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011140296A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals |
Triazoles as inhibitors of fatty acid synthase
|
CA2798330A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
ES2718844T3
(en)
|
2010-05-07 |
2019-07-04 |
Greenlight Biosciences Inc |
Methods to control the flow in metabolic pathways by relocating enzymes
|
CA3041113C
(en)
|
2010-05-11 |
2022-01-18 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
CN103180318B
(en)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
male contraceptive compositions and methods of use
|
US9193989B2
(en)
|
2010-06-18 |
2015-11-24 |
Taiho Pharmaceutical Co., Ltd. |
PRPK-TPRKB modulators and uses thereof
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
CN108570097A
(en)
|
2010-08-13 |
2018-09-25 |
爱勒让治疗公司 |
Peptidomimetic macrocyclic compound
|
EP3219796B1
(en)
|
2010-08-31 |
2020-10-07 |
GreenLight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
JP5856621B2
(en)
|
2010-09-15 |
2016-02-10 |
ゾゲニクス インコーポレーティッド |
Needleless syringe and its design parameters to optimize injection performance
|
WO2012040406A2
(en)
|
2010-09-21 |
2012-03-29 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
DE19177059T1
(en)
|
2010-10-01 |
2021-10-07 |
Modernatx, Inc. |
RIBONUCLEIC ACID CONTAINING N1-METHYL-PSEUDOURACILE AND USES
|
RU2663718C2
(en)
|
2010-10-04 |
2018-08-08 |
Массачусетс Инститьют Оф Текнолоджи |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
EP2438945A1
(en)
*
|
2010-10-08 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Reusable engine for an auto-injector
|
JP2013545749A
(en)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Heterocyclic compounds and uses thereof
|
BR112013017670B1
(en)
|
2011-01-10 |
2022-07-19 |
Infinity Pharmaceuticals, Inc |
PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
|
BR112013017561A2
(en)
*
|
2011-01-10 |
2016-10-11 |
Zogenix Inc |
needle-less injectors
|
US9089579B2
(en)
|
2011-01-19 |
2015-07-28 |
Topokine Therapeutics, Inc. |
Methods and compositions for treating metabolic syndrome
|
SG10201804552WA
(en)
|
2011-01-24 |
2018-07-30 |
Anterios Inc |
Nanoparticle compositions, formulations thereof, and uses therefor
|
WO2012103037A1
(en)
|
2011-01-24 |
2012-08-02 |
Anterios, Inc. |
Oil compositions
|
TR201905477T4
(en)
|
2011-01-24 |
2019-05-21 |
Anterios Inc |
Nano-particle compositions.
|
JP5794786B2
(en)
*
|
2011-02-04 |
2015-10-14 |
株式会社ダイセル |
Needleless syringe
|
MX2013010076A
(en)
|
2011-03-03 |
2014-04-07 |
Tersus Pharmaceuticals Llc |
COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE.
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
EP2691396B1
(en)
|
2011-03-30 |
2016-08-10 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
DE12722942T1
(en)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
RELEASE AND FORMULATION OF MANIPULATED NUCLEIC ACIDS
|
AU2012257771C1
(en)
|
2011-05-17 |
2015-12-03 |
Glaxosmithkline Biologicals S.A. |
Vaccine against Streptococcus pneumoniae
|
JP6061922B2
(en)
|
2011-06-22 |
2017-01-18 |
ザ ジェネラル ホスピタル コーポレイション |
How to treat proteinopathy
|
WO2013012915A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
KR20140063605A
(en)
|
2011-07-19 |
2014-05-27 |
인피니티 파마슈티칼스, 인코포레이티드 |
Heterocyclic compounds and uses thereof
|
PL2734510T3
(en)
|
2011-07-22 |
2019-05-31 |
Massachusetts Inst Technology |
Activators of class i histone deacetlyases (hdacs) and uses thereof
|
MX2014002542A
(en)
|
2011-08-29 |
2014-07-09 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof.
|
CN104093848A
(en)
|
2011-09-09 |
2014-10-08 |
绿光生物科学公司 |
Cell-free preparation of carbapenems
|
KR20190015765A
(en)
|
2011-09-09 |
2019-02-14 |
랜티우스 메디컬 이메징, 인크. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
WO2013039861A2
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
JP6113737B2
(en)
|
2011-10-03 |
2017-04-12 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
Modified nucleosides, nucleotides and nucleic acids and methods for their use
|
MX358886B
(en)
|
2011-10-18 |
2018-08-31 |
Aileron Therapeutics Inc |
Peptidomimetic macrocyles.
|
US9382239B2
(en)
|
2011-11-17 |
2016-07-05 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-terminal kinase (JNK)
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
MX2014007233A
(en)
|
2011-12-16 |
2015-02-04 |
Moderna Therapeutics Inc |
Modified nucleoside, nucleotide, and nucleic acid compositions.
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
US8987414B2
(en)
|
2012-02-15 |
2015-03-24 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
SG11201404648PA
(en)
|
2012-02-15 |
2014-09-26 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles
|
US9273084B2
(en)
|
2012-04-06 |
2016-03-01 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP2850091A1
(en)
|
2012-04-06 |
2015-03-25 |
President and Fellows of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
US9902985B2
(en)
|
2012-04-06 |
2018-02-27 |
President And Fellows Of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
US20140142500A1
(en)
|
2012-04-23 |
2014-05-22 |
Zogenix, Inc. |
Piston closures for drug delivery capsules
|
EP3492101A3
(en)
|
2012-05-10 |
2019-10-23 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
CA2879939A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
AU2013306098A1
(en)
|
2012-08-18 |
2015-02-12 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
JP6437436B2
(en)
*
|
2012-08-30 |
2018-12-12 |
エルテーエス ローマン テラピー−ジステーメ アーゲー |
Test device for loading a substance into a medium
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
HUE043853T2
(en)
|
2012-10-12 |
2019-09-30 |
Broad Inst Inc |
Gsk3 inhibitors and methods of use thereof
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
US9758522B2
(en)
|
2012-10-19 |
2017-09-12 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
EP2914296B2
(en)
|
2012-11-01 |
2021-09-29 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
EP2914256B1
(en)
|
2012-11-01 |
2019-07-31 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
EP2922542A4
(en)
|
2012-11-21 |
2016-10-05 |
Topokine Therapeutics Inc |
Methods and compositions for locally increasing body fat
|
JP6408478B2
(en)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Trioxacalcin, trioxacalcin-antibody complex and use thereof
|
CA2892529C
(en)
|
2012-11-26 |
2023-04-25 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
EP2742963A1
(en)
*
|
2012-12-17 |
2014-06-18 |
Sanofi-Aventis Deutschland GmbH |
Drug delivery device
|
US9745291B2
(en)
|
2012-12-21 |
2017-08-29 |
Epizyme, Inc. |
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
US9908887B2
(en)
|
2012-12-21 |
2018-03-06 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
EP2935241A1
(en)
|
2012-12-21 |
2015-10-28 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
JP6678455B2
(en)
|
2012-12-21 |
2020-04-08 |
エピザイム,インコーポレイティド |
PRMT5 inhibitors and uses thereof
|
JP2016504050A
(en)
|
2013-01-17 |
2016-02-12 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
Signal sensor polynucleotide for modification of cell phenotype
|
US11576958B2
(en)
|
2013-02-07 |
2023-02-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
CA2898633C
(en)
|
2013-02-07 |
2021-07-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
AU2014249008B2
(en)
|
2013-03-11 |
2018-12-06 |
Durect Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
CN110105434A
(en)
|
2013-03-13 |
2019-08-09 |
哈佛大学的校长及成员们 |
The polypeptide and application thereof of stitching and suture
|
US20160024051A1
(en)
|
2013-03-15 |
2016-01-28 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
CN105188741A
(en)
|
2013-04-03 |
2015-12-23 |
阿勒丁医疗公司 |
Novel nanoparticle compositions
|
CN105246334A
(en)
|
2013-04-04 |
2016-01-13 |
哈佛大学的校长及成员们 |
Macrolides and methods of their preparation and use
|
US9381253B2
(en)
|
2013-04-09 |
2016-07-05 |
Massachusetts Institute Of Technology |
Drug delivery polymer and uses thereof
|
US10301359B2
(en)
|
2013-04-30 |
2019-05-28 |
Massachusetts Institute Of Technology |
Human adaptation of H3 influenza
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(en)
|
2013-05-10 |
2018-06-16 |
|
|
CA2914284A1
(en)
|
2013-05-30 |
2014-12-04 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
AU2014278231B2
(en)
|
2013-06-11 |
2017-05-25 |
KALA BIO, Inc. |
Urea derivatives and uses thereof
|
WO2014201370A1
(en)
|
2013-06-14 |
2014-12-18 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
WO2015013635A2
(en)
|
2013-07-25 |
2015-01-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
SG11201600709TA
(en)
|
2013-08-05 |
2016-02-26 |
Glaxosmithkline Biolog Sa |
Combination immunogenic compositions
|
US9688977B2
(en)
|
2013-08-05 |
2017-06-27 |
Greenlight Biosciences, Inc. |
Engineered phosphoglucose isomerase proteins with a protease cleavage site
|
US9782476B2
(en)
|
2013-09-06 |
2017-10-10 |
Academia Sinica |
Human iNKT cell activation using glycolipids with altered glycosyl groups
|
ES2900806T3
(en)
|
2013-10-04 |
2022-03-18 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US9982009B2
(en)
|
2013-10-15 |
2018-05-29 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
WO2015057958A2
(en)
|
2013-10-16 |
2015-04-23 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
EP3057956B1
(en)
|
2013-10-18 |
2021-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
AU2014342042B2
(en)
|
2013-11-01 |
2017-08-17 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
CA2929652A1
(en)
|
2013-11-08 |
2015-05-14 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
|
EA201891279A1
(en)
|
2013-12-24 |
2019-01-31 |
Президент Энд Феллоус Оф Гарвард Колледж |
ANALOGUES OF CORTISTATIN, THEIR SYNTHESIS AND APPLICATIONS
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3094352B1
(en)
|
2014-01-16 |
2020-09-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
JP2017504651A
(en)
|
2014-01-31 |
2017-02-09 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
Use of diazepan derivatives
|
WO2015131113A1
(en)
|
2014-02-28 |
2015-09-03 |
Tensha Therapeutics, Inc. |
Treatment of conditions associated with hyperinsulinaemia
|
MX2016011517A
(en)
|
2014-03-07 |
2017-04-13 |
Univ Arizona |
Non-narcotic crmp2 peptides targeting sodium channels for chronic pain.
|
DK3119397T3
(en)
|
2014-03-19 |
2022-03-28 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds for use in the treatment of PI3K-gamma-mediated disorders
|
WO2015148915A1
(en)
|
2014-03-27 |
2015-10-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
ES2868305T3
(en)
|
2014-03-28 |
2021-10-21 |
Univ Washington Through Its Center For Commercialization |
Vaccines against breast and ovarian cancer
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
WO2015172686A1
(en)
*
|
2014-05-14 |
2015-11-19 |
苏州大学张家港工业技术研究院 |
Pneumatic accumulating needleless syringe
|
JP6759109B2
(en)
|
2014-05-21 |
2020-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
RAS inhibitory peptides and their use
|
KR20220151036A
(en)
|
2014-05-27 |
2022-11-11 |
아카데미아 시니카 |
Anti-cd20 glycoantibodies and uses thereof
|
CA2950577A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Fucosidase from bacteroides and methods using the same
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
AU2015267045B2
(en)
|
2014-05-27 |
2021-02-25 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
KR102494193B1
(en)
|
2014-05-28 |
2023-01-31 |
아카데미아 시니카 |
Anti-tnf-alpha glycoantibodies and uses thereof
|
CA2951430A1
(en)
|
2014-06-13 |
2015-12-17 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
DK3157916T3
(en)
|
2014-06-19 |
2019-03-18 |
Ariad Pharma Inc |
HETEROARYL COMPOUNDS FOR CHINESE INHIBITION
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
JP6820830B2
(en)
|
2014-07-18 |
2021-01-27 |
ユニヴァーシティ オブ ワシントン |
Cancer vaccine composition and how to use it
|
WO2016025643A1
(en)
|
2014-08-12 |
2016-02-18 |
Massachusetts Institute Of Technology |
Brush-poly(glycoamidoamine)-lipids and uses thereof
|
EP3191500A4
(en)
|
2014-09-08 |
2018-04-11 |
Academia Sinica |
HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
|
JP2017533889A
(en)
|
2014-09-24 |
2017-11-16 |
エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. |
Peptidomimetic macrocycles and uses thereof
|
CN112972378A
(en)
|
2014-09-24 |
2021-06-18 |
艾瑞朗医疗公司 |
Peptidomimetic macrocycles and formulations thereof
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EP3760618A1
(en)
|
2014-10-21 |
2021-01-06 |
ARIAD Pharmaceuticals, Inc. |
Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl]pyrimidine-2,4-diamine
|
BR112017008714A2
(en)
|
2014-10-27 |
2017-12-19 |
Tensha Therapeutics Inc |
bromodomain inhibitors
|
JP2017533238A
(en)
|
2014-10-28 |
2017-11-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Compositions and methods for antigen-specific tolerance
|
EP3041948B1
(en)
|
2014-11-10 |
2019-01-09 |
Modernatx, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
US10253045B2
(en)
|
2014-11-26 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
US10174022B2
(en)
|
2014-12-10 |
2019-01-08 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof
|
KR102554779B1
(en)
|
2014-12-23 |
2023-07-11 |
슬로안-케테링인스티튜트퍼캔서리서치 |
Polymorph of granaticin b
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
EP3248005B1
(en)
|
2015-01-24 |
2020-12-09 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
EP3294318A4
(en)
|
2015-03-20 |
2019-04-03 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
JP6861166B2
(en)
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
Inhibitor of cyclin-dependent kinase
|
CR20170485A
(en)
|
2015-03-30 |
2018-02-05 |
Greenlight Biosciences Inc |
RIBONUCLEIC ACID PRODUCTION FREE OF CELLS
|
CN107708693A
(en)
|
2015-04-27 |
2018-02-16 |
佛罗里达大学研究基金会 |
Metal-chelator of Metabolic programming and application thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
JP6800410B2
(en)
|
2015-06-19 |
2020-12-16 |
マサチューセッツ インスティテュート オブ テクノロジー |
Alkenyl Substituents 2,5-Piperazinediones and Their Use in Compositions for Delivering Agents to Subjects or Cells
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US10023613B2
(en)
|
2015-09-10 |
2018-07-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of MCL-1
|
EP3350333B1
(en)
|
2015-09-17 |
2021-10-27 |
ModernaTX, Inc. |
Polynucleotides containing a stabilizing tail region
|
RS63030B1
(en)
|
2015-09-17 |
2022-04-29 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of therapeutic agents
|
US9925170B2
(en)
|
2015-10-01 |
2018-03-27 |
Kythera Biopharmaceuticals, Inc. |
Methods of adipolysis and compositions useful therein
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
JP7114465B2
(en)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
Compounds and compositions for intracellular delivery of drugs
|
WO2017156192A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
JP7011599B2
(en)
|
2016-04-06 |
2022-02-10 |
グリーンライト バイオサイエンシーズ インコーポレーテッド |
Cell-free production of ribonucleic acid
|
CN115746107A
(en)
|
2016-06-03 |
2023-03-07 |
圣诺菲·帕斯图尔公司 |
Modification of engineered influenza hemagglutinin polypeptides
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10751476B2
(en)
|
2016-06-09 |
2020-08-25 |
Becton, Dickinson And Company |
Actuator assembly for drug delivery system
|
US10603445B2
(en)
|
2016-06-09 |
2020-03-31 |
Becton, Dickinson And Company |
Needle actuator assembly for drug delivery system
|
US10792432B2
(en)
|
2016-06-09 |
2020-10-06 |
Becton, Dickinson And Company |
Drive assembly and spacer for drug delivery system
|
US10549044B2
(en)
|
2016-06-09 |
2020-02-04 |
Becton, Dickinson And Company |
Spacer assembly for drug delivery system
|
EP3468537A1
(en)
|
2016-06-14 |
2019-04-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
CN109890415B
(en)
|
2016-08-05 |
2023-04-04 |
圣诺菲·帕斯图尔公司 |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
CN109862908B
(en)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
CN109963868B
(en)
|
2016-08-22 |
2023-11-14 |
醣基生医股份有限公司 |
Antibodies, binding fragments, and methods of use
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
JP7332478B2
(en)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
Lipid nanoparticle formulation
|
SG11201907916TA
(en)
|
2017-03-15 |
2019-09-27 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of therapeutic agents
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
EP3638678A1
(en)
|
2017-06-14 |
2020-04-22 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
CN111065417B
(en)
|
2017-06-23 |
2024-04-19 |
美商艾芬尼维克斯公司 |
Immunogenic compositions
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds and uses thereof
|
EP3675817A1
(en)
|
2017-08-31 |
2020-07-08 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
EP3695002A1
(en)
|
2017-10-11 |
2020-08-19 |
GreenLight Biosciences, Inc. |
Methods and compositions for nucleoside triphosphate and ribonucleic acid production
|
BR112020007533A2
(en)
|
2017-10-16 |
2020-10-06 |
Becton, Dickinson And Company |
spacer set for drug delivery device
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
JP2022501367A
(en)
|
2018-09-20 |
2022-01-06 |
モデルナティエックス インコーポレイテッドModernaTX, Inc. |
Preparation of lipid nanoparticles and method for administration thereof
|
EP3911644A1
(en)
|
2019-01-16 |
2021-11-24 |
Curza Global LLC |
Antimicrobial compounds and methods
|
CN113825748A
(en)
|
2019-01-16 |
2021-12-21 |
库扎环球有限责任公司 |
Antimicrobial compounds and methods
|
AU2020214843A1
(en)
|
2019-01-31 |
2021-08-19 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
AU2020323498A1
(en)
|
2019-07-31 |
2022-03-03 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
JP2022543773A
(en)
|
2019-07-31 |
2022-10-14 |
モデルナティエックス インコーポレイテッド |
Compositions and methods for delivery of RNA interfering agents to immune cells
|
AU2020384885A1
(en)
|
2019-11-13 |
2022-06-09 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
MX2022009410A
(en)
|
2020-01-31 |
2022-10-18 |
Modernatx Inc |
Methods of preparing lipid nanoparticles.
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
US20230174576A1
(en)
|
2020-10-30 |
2023-06-08 |
Xeno-Interface Inc. |
Beta-strand bridge peptide
|
WO2022092294A1
(en)
|
2020-10-30 |
2022-05-05 |
学校法人慶應義塾 |
Novel treatment and prevention of sarcopenia-related diseases
|
AR124267A1
(en)
|
2020-12-09 |
2023-03-01 |
Genentech Inc |
HIGH THROUGH METHODS FOR PREPARING LIPID NANOPARTICLES AND THEIR USES
|
WO2022146931A1
(en)
*
|
2021-01-03 |
2022-07-07 |
Fpin Llc |
Damped autoinjectors
|
WO2022192176A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(en)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
Compounds for treating genetic diseases
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
US20230233667A1
(en)
|
2021-09-08 |
2023-07-27 |
Affinivax, Inc. |
Coronavirus vaccine
|
WO2023059857A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
TW202333654A
(en)
|
2021-12-16 |
2023-09-01 |
美商現代公司 |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|
WO2024091918A2
(en)
|
2022-10-25 |
2024-05-02 |
Modernatx, Inc. |
Methods of lipid nanoparticle production in cross-mixers
|